Literature DB >> 29935940

Assessment and management of cauda equina syndrome.

Sue Greenhalgh1, Laura Finucane2, Chris Mercer3, James Selfe4.   

Abstract

INTRODUCTION: Cauda equina syndrome (CES) is a rare condition that affects the nerves in the spine supplying the bladder, bowel and sexual function. Identification and subsequent urgent action is required to avoid permanent damage to these essential organs. Delays in diagnosis can have devastating and life changing consequences for patients and result in high cost negligence claims.
PURPOSE: The purpose of this masterclass is to examine the current evidence and provide an evidence-based, clinically reasoned approach in the safe management of patients presenting with CES. It will include a focus on the importance of communication, documentation and a practical approach to safety netting those at risk. IMPLICATIONS FOR PRACTICE: CES has significant implications for patients and clinicians alike. Timely, effective diagnosis and management of patients with CES results in a better outcome. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cauda equina syndrome; Masqueraders; Red flags; Safety netting

Mesh:

Year:  2018        PMID: 29935940     DOI: 10.1016/j.msksp.2018.06.002

Source DB:  PubMed          Journal:  Musculoskelet Sci Pract        ISSN: 2468-7812            Impact factor:   2.520


  3 in total

1.  Vocal fold paralysis and cauda equina syndrome following spinal-epidural anesthesia: A case report.

Authors:  Yuanling Xiang; Weifeng Wang; Shenfeng Jing; Zhong Zhang; Dezhang Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

2.  Lower Back Pain Heralding Cauda Equina Syndrome in a Patient With Achondroplasia.

Authors:  Ting-Yu Lin; Chun-Sheng Ho; Ke-Vin Chang; Wei-Ting Wu; Levent Ozcakar
Journal:  Cureus       Date:  2022-02-19

3.  Medico-legal litigation of UK physiotherapists in relation to cauda equina syndrome: a multimethods study.

Authors:  Gillian Yeowell; Rachel Leech; Susan Greenhalgh; Emma Willis; James Selfe
Journal:  BMJ Open       Date:  2022-07-12       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.